In this largest reported series, magnetic sphincter augmentation implantation is associated with very good clinical and objective outcomes in gastroesophageal reflux disease patients.
https://t.co/k2MsFR89QO
@Sayazi@knewhamsMDMPH@JobeBlair#VisualAbstract#SoMe4Surgery
Most patients that develop esophageal cancer had never been screened prior to diagnosis. Cytosponge represents a East test by which we may be able to screen at risk populations on a large scale. The AHN Esophageal Institute launched its screening program yesterday.
Our recent study in @JAmCollSurg: Age <45 yrs, male sex, GERD-HRQL total score >15 and abnormal DeMeester score are the 4 preoperative factors predicting a favorable outcome after magnetic sphincter augmentation (LINX).
https://t.co/D828bF1Zz9
@ForegutSociety, @AmCollSurgeons
Esophageal Cancer Awareness 5K Walk/Run
Register for the Esophageal Cancer Awareness 5K:
https://t.co/z99OtNFxUq
Want to support the event, but don’t want to participate? Go to: https://t.co/tOch7AeSU1 to start fundraising
Our recent study in the January issue of the Journal of Gastrointestinal Surgery
Dysphagia after Magnetic Sphincter Augmentation (MSA): Characterization, Clinical Risk Factors, and Management
https://t.co/FPsktr0vAs
@JournalofGISurg@JobeBlair